Adcirca

Generic Name: Adcirca

What is Adcirca?

If you have ever had an obstruction in the gullet the oesophagus - the tube connecting the throat to the stomach. If you have been told that you have a narrowing of the aortic heart valve stenosis. If you have ever had a collapse caused by a heart problem cardiogenic shockduring which you became breathless, pale and had a cold sweat and dry mouth.

If your blood pressure continues to rise despite treatment malignant hypertension. Tell your doctor and do not take Adalat LA if any of these apply to you. Warnings and precautions Talk to your doctor before taking Adalat LA If you have low blood pressure and you were prescribed Adalat LA for your angina.

Your blood pressure may be decreased further by this treatment. If you have a heart condition where your heart cannot cope with increased strain poor cardiac reserve.

The adalat will be held at the corporation office from May 16 to 18. The decision to conduct the special adalat was taken based on complaints about the delay in getting their pensions. Applications of beneficiaries who have not been getting pensions since a year will be taken up at the adalat. The local self-government department has directed all the self-government bodies to conduct adalat at the earliest to resolve grievances of various pensioners availing social welfare pensions in its limit.

According to the corporation office, a total of 52,000 beneficiaries have been levying pensions under various schemes. Subjects are dosed with either Adalat or Coracten for first 2 weeks, followed by the other drug for 2 weeks, and then switched back to the original drug for one day.

Blood samples, blood pressure, and heart rate are taken before and after each treatment period. Exclusion Criteria:- Females who are pregnant, nursing or of childbearing age, unless sterilised. Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.

Click here to find results for studies related to marketed products. Hypertension Vascular Diseases Cardiovascular Diseases Nifedipine Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Vasodilator Agents Tocolytic Agents Reproductive Control Agents Physiological Effects of Drugs For Patients and Families For Researchers For Study Record Managers Home RSS Feeds Site Map Terms and Conditions Disclaimer Customer Support Copyright Privacy Accessibility Viewers and Players Freedom of Information Act USA.

National Library of Medicine U. National Institutes of Health U. Department of Health and Human Services Drug: Adalat Nifedipine, BAYA1040 Drug: Coracten Phase 4Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Open LabelPrimary Purpose: Basic ScienceEffects of Adalat LA 30 mg and Coracten 30 mg on Nifedipine Plasma ConcentrationPlasma Catecholamines, Blood Pressure Response and Heart Rate in Fed Mild to Moderate Hypertensive Patients.

Warning: The NCBI web site requires JavaScript to function.

How should I take Adcirca?

If you are using it to treat high blood pressure, you may take it with other drugs that lower blood pressure.

If you are using it to treat angina, you may take it with nitrates nitroglycerin products or beta-blockers. Nifedipine belongs to a class of drugs called calcium channel blockers.

A class of drugs is a group of medications that work in a similar way. These drugs are often used to treat similar conditions. Calcium channel blockers help lower blood pressure by relaxing the blood vessels throughout your body.

As a result, less pressure is built up and your heart does not have to work as hard to pump blood. Calcium channel blockers help to prevent angina in two ways.

What should I avoid while taking Adcirca?

Older adults should discuss the risks and benefits of this medication with their doctor or pharmacist, as well as other possibly safer forms of nifedipine such as the long-acting tablets. Take this medication by mouth, usually 3 times daily with or without food or as directed by your doctor.

Your doctor may gradually increase your dose. Follow your doctor's instructions carefully. Avoid eating grapefruit or drinking grapefruit juice while taking this medication unless your doctor instructs you otherwise. Grapefruit can increase the amount of certain medications in your bloodstream. Consult your doctor or pharmacist for more details. Use this medication regularly to get the most benefit from it.

Adcirca side effects

General Adalat CC should be taken on an empty stomach. Other versions of the drug can be taken either with food or on an empty stomach. Not every pharmacy stocks this drug. When filling your prescription, be sure to call ahead.

Keep it away from light. Refills A prescription for this medication is refillable. Travel When traveling with your medication: Always carry your medication with you or in your carry-on bag.

Common Adcirca ide effects may include:

  • In those men who are taking Adalat tablets and are repeatedly unsuccessful in fathering a child by in vitro fertilisation, the medicine should be considered as one of the possible causes if no other explanation can be found.

  • Some medicines and Adalat may interfere with each other.

  • Congestive heart failure warning: In rare cases, upon starting to take nifedipine, some patients without a history of heart failure have developed heart failure.

  • Therefore an increase of nifedipine plasma concentrations upon co-administration of both drugs cannot be excluded.

Carcinogenesis, Mutagenesis, Impairment Of Fertility Nifedipine was administered orally to rats for two years and was not shown to be carcinogenic. There are no adequate and well-controlled studies in pregnant women.

Nursing Mothers Nifedipine is excreted in human milk. Pediatric Use The safety and effectiveness of Adalat CC in pediatric patients have not been established.

More about Adcirca

Consumer resources

Other brands:Cheap viagra super active

Professional resources

Where can I get more information?

  • The Secretary of the Committee shall issue notices to the parties of the case for their consent to get the case decided by the Lok Adalat.

  • It is unknown how systemic exposure may be altered in patients with moderate or severe liver impairment.